Stock Rich List
#9374 on the rich list of 14,452 insiders

Jeffrey Poulton V.

EVP, Chief Financial Officer at Alnylam Pharmaceuticals. Based in Cambridge, Massachusetts.

$9.1M
in disclosed stock, −$98K (−1.06%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
9374th of 14,452
Companies held
1
Largest holding
ALNY, 100.0% of total
Latest SEC filing
Mar 4, 2026

What the $9.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Alnylam Pharmaceuticals ALNY
Common Stock
Directly61,805$147.82$9.1M99.9%Form 4, Mar 4, 2026
Alnylam Pharmaceuticals ALNY
Common Stock
Through Managed Account57$147.82$8K0.1%Form 4, Mar 4, 2026

Share counts are the amounts Jeffrey Poulton V. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Mar 4, 2026SoldALNY114$319.03$36KView
Mar 4, 2026SoldALNY109$320.01$35KView
Mar 4, 2026SoldALNY223$325.67$73KView
Mar 4, 2026SoldALNY818$323.84$265KView
Mar 4, 2026SoldALNY291$324.88$95KView
Mar 4, 2026SoldALNY230$320.81$74KView
Mar 4, 2026SoldALNY309$321.82$99KView
Mar 4, 2026SoldALNY374$323.01$121KView
Mar 2, 2026SoldALNY138$328.71$45KView
Mar 2, 2026SoldALNY234$329.71$77KView
Mar 2, 2026SoldALNY112$330.85$37KView
Mar 2, 2026SoldALNY129$331.93$43KView
Mar 2, 2026SoldALNY53$332.64$18KView
Mar 2, 2026SoldALNY541$326.81$177KView
Mar 2, 2026SoldALNY65$323.62$21KView
Mar 2, 2026SoldALNY124$324.65$40KView
Mar 2, 2026SoldALNY356$325.63$116KView
Mar 2, 2026SoldALNY454$327.67$149KView
Feb 13, 2026SoldALNY2,242$310.08$695KView
Jan 12, 2026SoldALNY72$353.95$25KView
Jan 12, 2026SoldALNY78$355.16$28KView
Jan 12, 2026SoldALNY76$356.09$27KView
Jan 12, 2026SoldALNY176$357.17$63KView
Jan 12, 2026SoldALNY226$358.18$81KView
Jan 12, 2026SoldALNY156$359.14$56KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
9371Lindsay A. Rosenwald Md
PRESIDENT, CEO & CHAIRMAN, Fortress Biotech. Bay Harbor Islands, FL
$9.1M−$598K (−6.14%)
9372Jonathan S. Mothner
See remarks, Synchrony Financial. Stamford, CT
$9.1M−$162K (−1.74%)
9373Adalio T. Sanchez
Director, ACI Worldwide. Elkhorn, NE
$9.1M−$387K (−4.06%)
9374Jeffrey Poulton V.
EVP, Chief Financial Officer, Alnylam Pharmaceuticals. Cambridge, MA
$9.1M−$98K (−1.06%)
9375Judd M. O.'Connor
Chief Commercial and Operation, Vylor. Wilmington, DE
$9.1M−$275K (−2.92%)
9376Wright Michael G.
10% owner, Conexeu Sciences
$9.1M−$1.2M (−11.68%)
9377Stephen R. Springer
Director, Atmos Energy. Dallas, TX
$9.1M−$161K (−1.73%)

Other Alnylam Pharmaceuticals insiders

All ALNY insiders

Questions

How much stock does Jeffrey Poulton V. own?

Jeffrey Poulton V. holds $9,144,441 in listed stock based on SEC filings and current prices, mostly Alnylam Pharmaceuticals (ALNY). That ranks 9374th on the Stock Rich List.

Is this Jeffrey Poulton V.'s net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Jeffrey Poulton V. last buy or sell stock?

The most recent open-market trade on file is a sale of 114 ALNY shares on Mar 4, 2026 at $319.03.